No Picture
San Diego Biotech Jobs

QC Scientist – San Diego, CA 92121

Company Description: Insmed is a global biopharmaceutical company on a mission to transform the lives of patients living… Click here to view original post


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Aptose Announces Receipt of Deficiency Notice from Nasdaq

SAN DIEGO and TORONTO, July 19, 2024 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing highly differentiated oral targeted agents to treat hematologic […]

No Picture
San Diego Biotech Jobs

Biochemist II

Profile insights Find out how your skills align with the job description Skills Do you have experience in Continuous improvement? Education Do you have a… Click here to view original post


ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks
News

Illumina to Present Upcoming Strategy Update

SAN DIEGO, July 18, 2024 /PRNewswire/ — As Illumina, Inc. (NASDAQ: ILMN) previously announced on June 24, the company will present a Strategy Update on Tuesday, August 13, 2024 starting at 8:00am Pacific Time. The […]


ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks
News

How will AI Shape Next Generation Wireless?

With 5G network connectivity now a reality, wireless industry and academic research leaders met at the San Diego Wireless Summit hosted by UC San Diego and Qualcomm Technologies, Inc., to assess the state of 5G, […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Clinical Data from Open-Label Extension LILAC-1™ and LILAC-2™ Studies Evaluating Long-Term Safety and Efficacy of DAYBUE™ (trofinetide) in Patients with Rett Syndrome Published in Med

SAN DIEGO–(BUSINESS WIRE)–Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the journal Med published results from two open-label extension studies, LILAC-1™ and LILAC-2™, which showed that patients treated with DAYBUE™ who completed these studies experienced […]

No Picture
News

Illumina Ventures Adds Two New Experts as Advisors

SAN FRANCISCO–(BUSINESS WIRE)– #biotech–Illumina Ventures today announced that Timothy Stenzel, MD, PhD, and Jerry Steiner have joined the team as Advisors. Click here to view original post Click Here to Publish/Feature Your Company or Product […]

News

Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules to Ease Administration for Patients Experiencing Dysphagia or Difficulty Swallowing

SAN DIEGO, July 18, 2024 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the launch of a new sprinkle formulation of INGREZZA® (valbenazine) capsules, the #1 prescribed vesicular monoamine transporter 2 (VMAT2) inhibitor indicated […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Calidi Biotherapeutics Announces Issuance of New U.S. Patent Covering Novel SuperNova Technology Platform

SAN DIEGO, July 18, 2024 (GLOBE NEWSWIRE) — Calidi Biotherapeutics, Inc. (NYSE American: CLDI or “Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced the issuance of a new […]

News

Ionis completes enrollment in pivotal trial evaluating zilganersen in people living with Alexander disease

Zilganersen is the first investigational medicine in clinical development for people with Alexander disease, a rare, life-threatening neurological condition CARLSBAD, Calif., July 18, 2024 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that it […]


ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks